Table 7 RNFL and GCC measurement and RCGcount in subgroups with different AL, without distinction of disease stage
Emmetropic PPG | Myopica PPG | Myopic Controlb | Non-highly myopicc | Highly myopicd | Emmetropic PPG vs Myopica PPG | Myopicb Control vs myopica PPG | Non-highly myopicc vs highly myopicd | |
|---|---|---|---|---|---|---|---|---|
P-values | ||||||||
MD (dB) | −0.98 (1.52) | −0.38 (1.69) | −0.69 (0.76) | −2.12 (6.09) | −3.58 (5.16) | 0.04 | 0.11 | 0.04 |
RNFL avg. (μm) | 97.17 (10.82) | 91.89 (9.07) | 107.66 (11.68) | 94.69 (13.23) | 86.46 (13.87) | 0.03 | <.001 | 0.002 |
RNFL sup (μm) | 98.01 (11.01) | 91.91 (10.55) | 107.51 (13.44) | 95.05 (13.26) | 88.15 (15.30) | 0.02 | <.001 | 0.06 |
RNFL inf (μm) | 96.31 (11.84) | 91.86 (11.85) | 107.81 (11.82) | 94.31 (14.57) | 84.78 (14.88) | 0.17 | <.001 | <.001 |
GCC avg. (μm) | 88.20 (6.68) | 84.12 (7.32) | 99.61 (6.16) | 84.77 (8.88) | 81.61 (11.78) | 0.01 | <.001 | 0.03 |
GCC sup (μm) | 88.99 (7.31) | 85.34 (7.19) | 99.00 (6.59) | 86.15 (8.62) | 83.43 (11.79) | 0.02 | <.001 | 0.04 |
GCC inf (μm) | 87.40 (7.04) | 82.94 (8.24) | 100.26 (6.37) | 83.41 (10.58) | 79.78 (13.14) | 0.03 | <.001 | 0.06 |
FLV % | 1.68 (2.22) | 3.46 (3.93) | 0.66 (0.87) | 4.22 (3.74) | 5.96 (5.39) | 0.002 | <.001 | 0.009 |
GLV % | 9.59 (5.71) | 15.18 (6.65) | 3.21 (2.53) | 15.19 (7.85) | 18.39 (10.28) | 0.008 | <.001 | 0.06 |
RGC count (n) | 1,002,394.31 (189,401.24) | 935,629.17 (121,851.31) | 1,116,479.27 (142,484.24) | 910,940.59 (226,819.93) | 784,036.59 (253,833.31) | <.001 | <.001 | <.001 |